Expression Table for this CRE
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 12.5 |
| CNhs14046 | iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 7.3 |
| CNhs12897 | H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 7.0 |
| CNhs11990 | Smooth Muscle Cells - Subclavian Artery, donor2 | 6.5 |
| CNhs11862 | bronchial squamous cell carcinoma cell line:KNS-62 | 5.0 |
| CNhs14376 | mesothelioma cell line:Mero-14 | 5.0 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 4.7 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 4.7 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 4.6 |
| CNhs14427 | COBL-a rinderpest infection, 12hr, biol_rep3 | 4.6 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 4.6 |
| CNhs12705 | MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 4.3 |
| CNhs11861 | medulloblastoma cell line:ONS-76 | 4.2 |
| CNhs12063 | Nucleus Pulposus Cell, donor3 | 4.1 |
| CNhs13647 | Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 3.6 |
| CNhs13835 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 3.6 |
| CNhs12403 | Fibroblast - skin normal, donor1 (nuclear fraction) | 3.3 |
| CNhs14238 | squamous cell lung carcinoma cell line:LC-1F | 3.3 |
| CNhs12054 | Bronchial Epithelial Cell, donor4 | 3.3 |
| CNhs12056 | Skeletal Muscle Cells, donor5 | 3.0 |
| SRX6586250 | CNhi10329_THP-1_Fluvastatin-30 uM-48h_rep3 | 2.9 |
| CNhs14572 | Myoblast differentiation to myotubes, day04, control donor2 | 2.8 |
| CNhs12000 | Dendritic Cells - monocyte immature derived, donor3 | 2.7 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 2.6 |
| CNhs14570 | Myoblast differentiation to myotubes, day02, control donor2 | 2.3 |
| CNhs12487 | MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 2.2 |
| CNhs11675 | Whole blood (ribopure), donor090309, donation1 | 2.2 |
| CNhs11905 | Neutrophils, donor3 | 2.2 |
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| SRX6586246 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep6 | 2.2 |
| SRX9760361 | skeletal muscle_2_min_after_exercise (Individual 3) | 2.2 |
| CNhs12704 | MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 2.2 |
| CNhs12046 | Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 2.2 |
| CNhs12040 | Skeletal Muscle Cells, donor3 | 2.1 |
| CNhs14057 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 2.1 |
| CNhs13840 | iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 2.1 |
| CNhs12523 | common myeloid progenitor CMP, donor2 | 2.0 |
| CNhs13049 | acute myeloid leukemia (FAB M7) cell line:M-MOK | 2.0 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 1.9 |
| SRX12709166 | Heart (Sample 50); the left and right atrial free wall, right and left ventricular base, and inferior and superior sinoatrial node | 1.8 |
| CNhs13344 | Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 1.8 |
| SRX17533228 | A-549 treated with TGF-beta1_01h_rep4 | 1.8 |
| SRX18306661 | TDP2 null mutant, Intact TDP2 overexpression_treated with Estrogen_6h, rep1 | 1.8 |
| SRX17533252 | MDA-231-D treated with TGF-beta1_01h_rep3 | 1.7 |
| CNhs13343 | Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 1.7 |
| CNhs12087 | Renal Proximal Tubular Epithelial Cell, donor2 | 1.7 |
| CNhs12036 | Osteoblast, donor3 | 1.7 |
| CNhs12057 | Fibroblast - Cardiac, donor5 | 1.7 |
| CNhs14568 | Myoblast differentiation to myotubes, day01, control donor2 | 1.7 |
| CNhs13345 | Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 1.7 |